semaglutide and intestinal obstruction FDA Updates Ozempic Label With Warning for Blockages semaglutide gastrointestinal obstruction legal team

If you or a loved one have suffered a serious side effect from taking a prescription drug, Fieger Law can help

Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, et al

Wilson JM et al (2020) The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes

Since these are the primary substances tested, many prescription and over-the-counter medications are not included in routine screenings unless specifically requested

As of March 29, 2026 , retatrutide remains investigational , not FDA approved